Can levamisole upregulate the equine cell‐mediated macrophage (M1) dendritic cell (DC1) T‐helper 1 (CD4 Th1) T‐cytotoxic (CD8) immune response in vitro?

BACKGROUND: Equine protozoal myeloencephalitis (EPM) is a common and devastating neurologic disease of horses in the United States. Because some EPM‐affected horses have decreased immune responses, immunomodulators such as levamisole have been proposed as supplemental treatments. However, little is...

Descripción completa

Detalles Bibliográficos
Autores principales: Witonsky, Sharon, Buechner‐Maxwell, Virginia, Santonastasto, Amy, Pleasant, Robert, Werre, Stephen, Wagner, Bettina, Ellison, Siobhan, Lindsay, David
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2019
Materias:
EQUID
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6430894/
https://www.ncbi.nlm.nih.gov/pubmed/30693587
http://dx.doi.org/10.1111/jvim.15404

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6430894/
https://www.ncbi.nlm.nih.gov/pubmed/30693587
http://dx.doi.org/10.1111/jvim.15404

Ejemplares similares